<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00249886</url>
  </required_header>
  <id_info>
    <org_study_id>ISRCTN42386710</org_study_id>
    <nct_id>NCT00249886</nct_id>
  </id_info>
  <brief_title>Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate whether it is advantageous for adolescents who have&#xD;
      recovered from depression after a 6 to 12 week course of antidepressant treatment to stay on&#xD;
      the treatment a further 6 months or is it just as helpful to stop the medication after&#xD;
      recovery.&#xD;
&#xD;
      The hypothesis is that adolescents with major depression who recover from the 6 to 12 week&#xD;
      trial of citalopram will be less likely to have a recurrence of depression over a 6 month&#xD;
      period if continued on the citalopram as compared to those who discontinue the medication.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>September 2002</start_date>
  <completion_date>November 2006</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relapse - subject meets criteria for an episode of major depression for 2 weeks or more.</measure>
  </primary_outcome>
  <enrollment>60</enrollment>
  <condition>Major Depression</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Citalopram</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of major Depression.&#xD;
&#xD;
          -  Age 13-18.&#xD;
&#xD;
          -  A score of &gt; 16 on the 17 item Hamilton Depression Scale or a score of &gt; 12 on the 17&#xD;
             items plus a score of &gt;7 on the atypical items.&#xD;
&#xD;
          -  Males and females.&#xD;
&#xD;
          -  Outpatient at initiation of double blind treatment phase.&#xD;
&#xD;
          -  Ability to give informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Past or current hypomanic or manic episode.&#xD;
&#xD;
          -  Currently meets criteria for a Conduct Disorder.&#xD;
&#xD;
          -  Current psychotic symptoms.&#xD;
&#xD;
          -  Substance dependence in the last 3 months.&#xD;
&#xD;
          -  Significant medical condition that would contraindicate the use of an antidepressant.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Past treatment with Citalopram for major depression&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony J Levitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2005</verification_date>
  <study_first_submitted>November 3, 2005</study_first_submitted>
  <study_first_submitted_qc>November 4, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2005</study_first_posted>
  <last_update_submitted>September 18, 2006</last_update_submitted>
  <last_update_submitted_qc>September 18, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citalopram</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

